Last reviewed · How we verify

NCT05365854: CHARM-ICU

Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers - ICU Patients

Status unknown NA Last updated 12 May 2022
What this trial tests

NA trial testing Alveolar Recruitment Maneuver (ARM) in Cardiac Output in 20 participants. Status unknown.

Timeline
1 March 2022
Primary endpoint
1 March 2024
1 March 2024

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposediagnostic
Enrollment20
Start date1 March 2022
Primary completion1 March 2024
Estimated completion1 March 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Cardiac Output or Hemodynamic Optimization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study was to investigate the hemodynamic effects of two alveolar recruitment maneuver strategies in critical care patients with acute respiratory distress syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Output

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05365854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing